Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications

Authors

LEGRAND M. LUDES P.O. MASSY Z. ROSSIGNOL P. PAŘENICA Jiří PARK J.J. ISHIHARA S. ALHABIB K.F. MAGGIONI A. MIRO O. SATO N. COHEN-SOLAL A. FAIRMAN E. LASSUS J. HARJOLA V.P. MUELLER C. PEACOCK F. CHOI D.J. PLAISANCE P. ŠPINAR Jindřich KOSIBOROD M. MEBAZAA A. GAYAT E.

Year of publication 2018
Type Article in Periodical
Magazine / Source Clinical Research in Cardiology
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.1007/s00392-017-1173-3
Keywords Mortality; Potassium; B-blockers; Heart failure; Renal failure
Description Background The interaction between chronic medications on admission and the association between serum potassium level and outcome in patients with acute heart failure (AHF) are unknown. Methods Observational intercontinental study of patients admitted with AHF. 15954 patients were included from 12 cohorts in 4 continents. Main outcome was 90-day mortality. Clinical presentation (medication use, hemodynamics, comorbidities), demographic, echocardiographic, and biochemical data on admission were recorded prospectively in each cohort, with prospective adjudication of outcomes. Results Positive and negative linear relationships between 90-day mortality and sK+ above 4.5 mmol/L (hyperkalemia) and below 3.5 mmol/L (hypo-kalemia) were observed. Hazard ratio for death was 1.46 [1.34-1.58] for hyperkalemia and 1.22 [1.06-1.40] for hypokalemia. In a fully adjusted model, only hyperkalemia remained associated with mortality (HR 1.03 [1.02-1.04] for each 0.1 mmol/l change of sK+ above 4.5 mmol/L). Interaction tests revealed that the association between hyperkalemia and outcome was significantly affected by chronic medications. The association between hyperkalemia and mortality was absent for patients treated with beta blockers and in those with preserved renal function. Conclusions In patients with AHF, sK+ > 4.5 mmol/L appears to be associated with 90-day mortality. B-blockers have potentially a protective effect in the setting of hyperkalemia.

You are running an old browser version. We recommend updating your browser to its latest version.

More info